Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Herpes simplex virus vaccines: perspectives].

C Deback1, J-M Huraux

  • 1Service de virologie du groupe hospitalier de la Pitié-Salpêtrière, 83, boulevard de l'Hôpital, 75651 Paris cedex 13, France. claire.deback@psl.aphp.fr

La Revue De Medecine Interne
|November 11, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Parvovirus B19-related peripheral nerve necrotizing vasculitis following SARS-CoV-2 infection.

Revue neurologique·2021
Same author

[Enteroviral infections in adults treated with rituximab: A new case of chronic meningitis and myofasciitis and literature review].

La Revue de medecine interne·2020
Same author

Expression pattern of the CXCL12/CXCR4-CXCR7 trio in Kaposi sarcoma skin lesions.

The British journal of dermatology·2016
Same author

Adapted treatment of Epstein-Barr virus infection to prevent posttransplant lymphoproliferative disorder after heart transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2014
Same author

[Measure of effectiveness and adherence to antiretroviral therapy in HIV-infected patients in Cameroon].

Medecine et maladies infectieuses·2010
Same author

Microsatellite analysis of HSV-1 isolates: from oropharynx reactivation toward lung infection in patients undergoing mechanical ventilation.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·2010
Same journal

[Atypical low back pain].

La Revue de medecine interne·2026
Same journal

[Polycythemia associated chronic haemolysis].

La Revue de medecine interne·2026
Same journal

[Persistent headaches in a 55 year-old man].

La Revue de medecine interne·2026
Same journal

[Abdominal pain, fever and arthralgia in a 49-year-old woman].

La Revue de medecine interne·2026
Same journal

[Cardiorespiratory functional disorders: A transnosologic approach].

La Revue de medecine interne·2026
Same journal

[Diagnostic evaluation for suspected polycythemia].

La Revue de medecine interne·2026
See all related articles

Herpes simplex virus (HSV) infection remains a significant public health concern. Developing effective vaccines requires a deeper understanding of immune responses to HSV.

Area of Science:

  • Virology
  • Immunology
  • Public Health

Context:

  • Herpes simplex virus (HSV) infections, particularly genital herpes, pose substantial social and psychological burdens.
  • HSV contributes to neonatal herpes and may increase HIV/AIDS transmission risk.
  • Current antiviral therapies are effective but do not prevent transmission or recurrence.

Purpose:

  • To highlight the ongoing public health challenges posed by HSV infections despite available treatments.
  • To underscore the limitations of current prophylactic and therapeutic vaccination strategies against HSV.
  • To emphasize the need for further research into HSV immunity.

Summary:

  • Despite effective antiviral treatments, herpes simplex virus (HSV) infections remain a critical public health issue.

Related Experiment Videos

  • Existing vaccination approaches have been unsuccessful, partly due to HSV's immune evasion mechanisms.
  • Identifying key determinants of immunity is crucial for developing effective HSV vaccines.

    • Impact:

    • Advances in understanding HSV immunity could lead to novel vaccine candidates.
    • Effective HSV vaccines would reduce the global burden of genital herpes, neonatal herpes, and potentially HIV transmission.
    • Improved vaccination strategies are essential to control HSV and mitigate its associated health impacts.